3 active not recruiting. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 3 |
| Phase 2 | 3 | Active not recruiting 3 |
Follow Ischemia: new trials by email Literature Review of Ischemia trials Research Report on Ischemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI Atibuclimab (IC14), 20 mg/kg intravenously, once, Placebo, 150 mL intravenously, once - STEMI, STEMI (ST Elevation MI) | Phase 1 / Phase 2 | Active not recruiting | Implicit Bioscience | 10 | 2025-02-06 | 2026-03-27 |
| A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C Istaroxime, Placebo - Cardiogenic Shock | Phase 1 / Phase 2 | Active not recruiting | Windtree Therapeutics | 20 | 2024-06-01 | 2025-08-20 |
| BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI) BGC101 (autologous EnEPC preparation), Control medium - Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease | Phase 1 / Phase 2 | Active not recruiting | BioGenCell Ltd. | 40 | 2016-06-01 | 2025-06-06 |
Chronic Limb-Threatening Ischemia (1) · Peripheral Arterial Disease (1) · Peripheral Vascular Diseases (1) · ST Elevation Myocardial Infarction (1) · Shock, Cardiogenic (1)
Cardiovascular Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Vascular Diseases (3) · Heart Diseases (2) · Infarction (2) · Myocardial Infarction (2) · Myocardial Ischemia (2) · Necrosis (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Chronic Disease (1) · Disease Attributes (1)
Istaroxime (1) · Lactic Acid (1) · atibuclimab (1)
BioGenCell Ltd. (1) · Implicit Bioscience (1) · Windtree Therapeutics (1)
United States (3) · Israel (2) · Argentina (1) · Italy (1) · Poland (1)
Alexander Reyzelman, MD (1) · Alisha Oropallo, MD (1) · Antonio Abbate, MD, PhD (1) · Caitlin Hicks, MD (1) · Edouard Aboian, MD (1) · Igor Laskowski, MD (1) · Jeffrey J Siracuse, MD (1) · Khanjan Nagarsheth, MD (1) · Marc Sintek, MD (1) · Mark Wyers, MD (1) · Michael Conte, MD (1) · Moshe Halak, MD (1) · Nathalie Moreels, MD (1) · Paata Meshveliani, MD (1) · Shlomo J Baytner, MD (1)